Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 6:17 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2209–2232 of 6,310 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Metabolism and Nutrition Disorders Clear all

Conditions: Child Obesity
Interventions: Wedge 1; Behavioral
Lead sponsor: Alaska Native Tribal Health Consortium; Other
Eligibility: 3 Years to 5 Years
Enrollment: 450 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Anchorage, Alaska

Conditions: Overweight and Obesity, Eating Behavior
Interventions: Placebo, Bromocriptine-QR; Drug
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 35 Years
Enrollment: 55 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Health Behavior, Diet, Healthy, Childhood Obesity
Interventions: Virtual Family-Based Healthy Plate Club; Behavioral
Lead sponsor: Inova Health Care Services; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Leesburg, Virginia

Conditions: Food Insecurity, Overweight and Obesity
Interventions: Not listed
Lead sponsor: University of New Hampshire; Other
Eligibility: 18 Years to 55 Years
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Durham, New Hampshire

Conditions: PreDiabetes, Obesity, Childhood
Interventions: Not listed
Lead sponsor: University of Michigan; Other
Eligibility: 8 Years to 22 Years
Enrollment: 772 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Obesity, Dysmobility
Interventions: Multi Modal Balance Training (MMBI), Weight Loss (WL); Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 60 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Mitochondrial Diseases
Interventions: test meal; Other
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 7 Years to 65 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Healthy Volunteers, Overweight, Obesity
Interventions: NNC9204-1177, Cocktail of 5 already approved drugs; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Obesity
Interventions: CP-945,598; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 2
States / cities: Anaheim, California • Miami, Florida

Conditions: Metabolism and Nutrition Disorder, Obesity
Interventions: semaglutide, liraglutide, placebo; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 957 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 22
States / cities: Anaheim, California • San Diego, California • Golden, Colorado + 18 more

Conditions: Pediatric Obesity, Weight Gain Trajectory, Infant Obesity
Interventions: Small Bottle Size, Standard Bottle Size, Clear Bottle, Opaque Bottle; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 3 Days to 1 Month
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Childhood Obesity, Prediabetes, Diabetes
Interventions: Not listed
Lead sponsor: Impeto Medical; Industry
Eligibility: 8 Years to 17 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2014
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Obesity, Metabolic Syndrome, Diabetes
Interventions: Recombinant methionyl human leptin; Drug
Lead sponsor: University of Miami; Other
Eligibility: 5 Years to 18 Years · Male only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Obese Adolescents, Obesity, Morbid, Obesity/Therapy
Interventions: Endoscopic Sleeve Gastroplasty (ESG) Procedure; Device
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 12 Years to 17 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), Celiac Disease, Diarrhea, Constipation, Microbiome, Crohn's Disease, UC - Ulcerative Colitis, Microscopic Colitis, Functional Dyspepsia
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 4,001 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Obesity, Overweight, Osteo Arthritis Knee
Interventions: Retatrutide, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 445 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 13
States / cities: Phoenix, Arizona • San Diego, California • Waterbury, Connecticut + 10 more

Conditions: Overweight, Obesity
Interventions: Eloralintide, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 1,035 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 60
States / cities: Birmingham, Alabama • Cullman, Alabama • Tucson, Arizona + 56 more

Conditions: Obesity
Interventions: COACH, School Readiness Intervention; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 4 Years and older
Enrollment: 301 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Childhood Obesity
Interventions: Husky Reads Intervention; Behavioral
Lead sponsor: UConn Health; Other
Eligibility: 35 Months to 71 Months
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Dietary Intervention, Gut Microbiota, Insulin Sensitivity/Resistance, Obesity & Overweight
Interventions: Whole grain sumac sorghum, Whole grain white sorghum, White rice; Other
Lead sponsor: University of Nebraska Lincoln; Other
Eligibility: 19 Years to 64 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: B-cell Acute Lymphoblastic Leukemia, Obesity
Interventions: IDEAL2 Intervention; Behavioral
Lead sponsor: Etan Orgel; Other
Eligibility: 7 Years to 25 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2032
U.S. locations: 16
States / cities: Los Angeles, California • Orange, California • San Francisco, California + 13 more

Conditions: Childhood Obesity
Interventions: AyuDa Virtual: Aprender y Utilizar Decisiones Apreciables (Spanish) - Learning and Utilizing Significant Choices (English), AyuDa Written: Aprender y Utilizar Decisiones Apreciables (Spanish) - Learning and Utilizing Significant Choices (English); Behavioral
Lead sponsor: Ana Maria Linares; Other
Eligibility: 2 Years to 60 Years
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 2
States / cities: Lexington, Kentucky

Conditions: X-Linked Hypophosphatemia
Interventions: burosumab, Oral Phosphate Supplement, active vitamin D; Biological · Drug
Lead sponsor: Kyowa Kirin, Inc.; Industry
Eligibility: 1 Year to 12 Years
Enrollment: 61 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 5
States / cities: Los Angeles, California • San Francisco, California • Indianapolis, Indiana + 2 more

Conditions: Abdominal Obesity, Hypertension
Interventions: Carvedilol CR + Lisinopril, Lisinopril + HCTZ; Drug
Lead sponsor: St. Paul Heart Clinic; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Search by objective public record fields.

More Outside Your Door: a Diet/physical Activity Intervention to Decrease Risk of Obesity in Alaska Native Preschoolers

Examination of Bromocriptine on Homeostatic and Hedonic Mechanisms of Food Intake in Individuals at High Risk for T2DM

Buen Provecho!: A Virtual Family-Based Intervention to Promote Health

Fiber-rich Foods, Weight Status, and the Gut Microbiota in NH Hispanic Adults at Risk for Food Insecurity

Conventional and Metabolomic Predictors of Prediabetes & Insulin Resistance

Multimodel Exercise and Weight Loss in Older Obese Veterans With Dysmobility

Glycemic Index in Mitochondrial Disease

Research Study to Investigate How a Study Medicine (NNC9204- 1177) Affects Blood Levels of Other Medicines in Healthy People

Study Examining The Effect Of Renal Impairment On Safety, Toleration And How The Body Processes An Experimental Drug

Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus

Assessing Better Bottles for Babies

Clinical Utility of SUDOSCAN in the Pediatric Population

Effects of Leptin Replacement in Children

ESG in Obese Adolescents

Enabling Microbiomics- Driven Personalized Nutrition

A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Competency Based Approaches for Community Health 2

Husky Reads Effectiveness in Increasing Produce Preference and Food Group Identification in Preschool Children

Phenolic Dependent And Independent Effects Of Whole Grain Sorghum On Immunometabolism

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Latinx Family Wellness

Efficacy and Safety of Burosumab Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With XLH

The Vascular Effects of Carvedilol Controlled Release (CR) in Abdominally Obese Hypertensive Patients